Pharmaceutical Preparation Manufacturing
Key Figures
Figures are published for NAICS 325412 directly.
Secure payments powered by Stripe, a PCI DSS Level 1 certified provider
Official definition
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
Source: US Census Bureau, 2017 NAICS Definitions. Public domain.
Which code does this activity belong in?
Pharmaceutical Preparation Manufacturing covers establishments that formulate and manufacture finished dose forms like tablets, capsules, and vials intended for consumption. This code differs from Medicinal and Botanical Manufacturing, which produces uncompounded chemical and botanical inputs rather than finished preparations. It excludes in-vitro diagnostic substances used in laboratory testing, classified in In-Vitro Diagnostic Substance Manufacturing, and biological products such as vaccines and blood fractions, which are classified in Biological Product Manufacturing.